CFDE Data Portal | Search CALML3

	Label	Description
	CALML3 Gene (Entity type)	ENSG00000178363 - calmodulin like 3
	CALML3 associations Collection (Entity type)	Associations for CALML3_associations
	CALML3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CALML3-AS1 associations Collection (Entity type)	Associations for CALML3-AS1_associations
	CALML3-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE48812 sulforaphane 4 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE149880 2 V 1 TAMOXIFEN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 4 V 10 SULFORAPHANE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE109913 1 V 2 BLEOMYCIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

CALML3

ENSG00000178363 - calmodulin like 3

CALML3 associations

Associations for CALML3_associations

CALML3 associations.tsv

A file from IDG as part of the Harmonizome project

CALML3-AS1 associations

Associations for CALML3-AS1_associations

CALML3-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

GSE48812 sulforaphane 4 v 10 human dn

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 5 human up

A Gene Set from LINCS

GSE149880 2 V 1 TAMOXIFEN MOUSE DN

A Gene Set from LINCS

GSE48812 4 V 10 SULFORAPHANE HUMAN DN

A Gene Set from LINCS

GSE109913 1 V 2 BLEOMYCIN MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.